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Abstract
Early maturation, indexed by pubertal development (PD), has been associated with earlier 
initiation and greater frequency of adolescent substance use, but this relationship may be biased by 
confounding factors and effects that change across development. Using a population-based Finnish 
twin sample (N=3,632 individuals), we conducted twin modeling and multilevel structural 
equation modeling of the relationship between PD and substance use at ages 12–22. Shared 
environmental factors contributed to early PD and heavier substance use for females. Biological 
father absence was associated with early PD for boys but not girls, and did not account for the 
relationship between PD and substance use. The association between early PD and heavier 
substance use was partially due to between-family confounds, although early PD appeared to 
qualitatively alter long-term trajectories for some substances (nicotine), but not others (alcohol). 
Mediation by peer and parental factors did not explain this relationship within families. However, 
higher peer substance use and lower parental monitoring were themselves associated with heavier 
substance use, strengthening the existing evidence for these factors as targets for prevention/
intervention efforts. Early maturation was not supported as a robust determinant of alcohol use 
trajectories in adolescence and young adulthood, but may require longer-term follow-up. Subtle 
effects of early PD on nicotine and illicit drug use trajectories throughout adolescence and 
adulthood merit further investigation.
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For adolescents, puberty is an important biological, psychological, and social milestone that 
marks a period of transition in each of these major developmental areas (Windle et al., 
2008). As the onset of puberty evokes both substantial physiological changes and shifts in 
adolescents’ social status and interpersonal relationships, experiencing early puberty may 
expose adolescents to novel challenges and experiences prior to the maturation of cognitive 
and emotional systems to cope with them, while simultaneously distancing early maturers 
from their same-age peers with later pubertal timing (Simmons & Blyth, 1987; Windle et al., 
2008). Accordingly, there has been great interest in the consequences of early pubertal 
development (PD; measured as the maturation of physical sexual characteristics). Many 
studies have established a link between early PD (relative to one’s peers) and numerous 
behavioral and emotional outcomes, including earlier substance use initiation as well as 
more frequent substance use in adolescence (Dick, Rose, Viken, & Kaprio, 2000; Graber, 
Lewinsohn, Seeley, & Brooks-Gunn, 1997; Jones, 1965; Kaltiala-Heino, Koivisto, 
Marttunen, & Fröjd, 2011; Richards & Oinonen, 2011; Stattin & Magnusson, 1990).
This association between early PD and substance use in adolescence is important, because 
early-onset alcohol use is a robust risk factor for later alcohol abuse and/or dependence 
(Huurre et al., 2010; U.S. Department of Health and Human Services, 2007), and early-onset 
nicotine use similarly predicts the development of nicotine dependence (Hartz et al., 2012). 
Adolescence is a critical period for neurodevelopment, as well as for establishing lifelong 
behavioral habits (Crews, He, & Hodge, 2007; Windle et al., 2008). Evidence from animal 
models and human studies suggests that initiation of substance use during early adolescence 
affects critical pathways in the brain and can lead to long-term neurological impacts 
including addiction and cognitive impairments (Alfonso-Loeches & Guerri, 2011; Koskinen 
et al., 2011; Schramm-Sapyta, Walker, Caster, Levin, & Kuhn, 2009; Windle, 2008). In 
addition, PD has been implicated in neurodevelopmental changes increasing sensitivity to 
rewarding stimuli (Forbes et al., 2010) and sensation-seeking behaviors (Martin et al., 2002), 
both of which may increase the likelihood of initiating and using psychoactive substances 
with rewarding properties. If early PD leads to substance use initiation during a critical 
neurodevelopmental period, it may qualitatively alter lifelong trajectories of substance use 
and substance-related problems. Beyond the risk of abuse or dependence in adulthood, 
substance use in adolescence is itself associated with a number of negative outcomes, 
including learning deficits (Crews et al., 2007), risky sexual behaviors (Windle et al., 2008), 
injury and assault (Kypri et al., 2009), and suicidal ideation and attempts (Riala et al., 2007).
Whereas pubertal timing itself is an unsuitable target for preventing early adolescent 
substance use, the relationship between early PD and substance use/initiation is likely 
mediated by modifiable psychosocial factors that are influenced by changes in pubertal 
status. During early adolescence, peers and parents are prominent sources of influence on 
adolescent behavior and particularly on substance use (Kelly et al., 2012; Korhonen et al., 
2008; Schulte, Ramo, & Brown, 2009; Windle et al., 2008). Evidence suggests that the 
Savage et al. Page 2
Dev Psychopathol. Author manuscript; available in PMC 2018 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
relationship between early maturation and substance use is mediated by increased affiliation 
with substance-using peers and decreased parental monitoring/involvement (Negriff & 
Trickett, 2012; Schelleman-Offermans, Knibbe, & Kuntsche, 2013; Westling, Andrews, 
Hampson, & Peterson, 2008). Responding to their more mature physical characteristics, 
parents and peers may begin to treat adolescents in more adult ways (for parents, this may 
mean giving their children more independence and less oversight) (Simmons & Blyth, 
1987), and adolescents themselves may begin to self-select into peer groups that participate 
in perceived “grown-up” activities like smoking and drinking alcohol. Some studies suggest 
that early-maturing girls have greater exposure to substance use due to affiliation with older 
peers and older boyfriends (Stattin & Magnusson, 1990; Westling et al., 2008), and there is 
also evidence that a similar mechanism of peer influence increases risk for substance use in 
early-maturing boys (Negriff & Trickett, 2012).
A major limitation of the existing literature is the largely untested assumption that because 
early PD is linked to earlier onset or increased substance use in early to middle adolescence, 
it will continue to be a risk factor for heavy or problematic substance use in adulthood as 
well. An alternative possibility is that this association merely reflects a temporal (rather than 
qualitative) shift in trajectories such that early-maturing individuals begin using substances 
earlier but late-maturing individuals subsequently catch-up later in development (e.g. Dick et 
al., 2000). There have been few empirical examinations of the trajectory of this association 
beyond adolescence that allow comparative testing of these two hypotheses. In the few 
existing studies with older samples, results suggest that the association between early PD 
and alcohol use in girls becomes non-significant by age 17 (Kaltiala-Heino et al., 2011) or 
reverses direction by age 22 (Richards & Oinonen, 2011), such that late-maturing girls 
become the heavier drinkers. Heavier drinking in late maturating girls was also seen in 
another sample composed primarily of older adolescents (age range: 11–17) (Marklein, 
Negriff, & Dorn, 2009). In contrast, Biehl et al. (2007) reported a continued association of 
early PD with higher alcohol use into adulthood for females. For boys, both early and late 
maturation has been linked to heavier drinking in late adolescence/early adulthood (Graber 
et al., 2004; Kaltiala-Heino et al., 2011). The majority of studies that have found a 
significant positive association between early PD and substance use have not examined 
whether this association persists into young adulthood. The conflicting findings that have 
been reported in emerging adulthood suggest that a number of additional factors are likely to 
be involved, creating a more complex relationship between PD and later patterns of 
substance use.
Another limitation in the existing literature is that the most commonly used indicator of PD 
is age at menarche. Although this measure can be easily and reliably ascertained and 
recalled in retrospective reports more accurately than other PD indicators (Koo & Rohan, 
1997), it is only one of many facets of puberty, and it is but moderately correlated with other 
indicators such as growth spurt and body hair development (Biro et al., 2006; Widén et al., 
2012). A second and obvious problem with age of menarche is that it excludes males, 
resulting in a deficit in current knowledge of how early maturation relates to substance use 
in boys. There is mixed evidence regarding whether early maturation is associated with 
substance use equally for boys and girls (Arim, Tramonte, Shapka, Dahinten, & Willms, 
2011; Graber et al., 1997; Harrell, Bangdiwala, Deng, Webb, & Bradley, 1998; Rose, Dick, 
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Viken, Pulkkinen, & Kaprio, 2001). There are substantial gender differences in the 
adolescent trajectories of both pubertal development (Windle et al., 2008) and substance use 
(Schulte et al., 2009), but few studies have included both males and females in the same 
protocol to compare sex differences in the relationship between PD and substance use. Thus 
it is unclear whether factors defining the relationship between PD and substance use, 
potentially including direct causal factors, differ between males and females.
Finally, studies comparing individuals from different families, a design characterizing 
virtually all studies in this area, may lead to spurious results due to between-family factors 
that can confound the relationship between variables. These between-family factors, 
including familial socioeconomic status, family structure (especially absence of the 
biological father), and familial conflict, are associated with both early PD and increased 
adolescent substance use (Arim et al., 2011; Deardorff et al., 2011; Kim & Smith, 1998; 
Mustanski, Viken, Kaprio, Pulkkinen, & Rose, 2004; Quinlan, 2003). Evolutionary theory 
suggests that childhood environments in which there is an absence of models of enduring, 
stable relationships and/or a scarcity of resources prime individual development towards 
achieving short-term reproductive success, for which earlier puberty provides an advantage 
(Arim et al., 2011; Belsky et al., 1991). Biological father absence has repeatedly shown an 
association with early PD, and may directly impact PD as well as reflecting a shared genetic 
liability or indexing other factors relevant to early maturation such as familial stress and 
socioeconomic status. The relationship between biological father absence and accelerated 
PD has primarily been found in females, although a few studies have identified a similar 
relationship in both genders (Bogaert, 2005; Kim & Smith, 1998; Mustanski et al., 2004).
Social and environmental factors that differ systematically between families may 
additionally complicate the PD-substance use association. A previous study found that early 
PD was associated with substance use only in families with high levels of household risk 
(e.g. low levels of resources and/or high levels of conflict; Lynne-Landsman, Graber, & 
Andrews, 2010). Accordingly, population-based studies that do not take into account such 
between-family differences may not be fully informative as to the relevant pathways of risk. 
To control for possible between-family confounds, it is necessary to use age-matched 
individuals reared in the same environment, for which samples of twins provide an ideal 
solution. To our knowledge, only one study has examined the association between early PD 
and substance use in twins, by comparing substance use in female twins discordant for age 
at menarche by two or more years (Dick et al., 2000). Using longitudinal data from the 
population-based FinnTwin16 study (Kaprio, Pulkkinen, & Rose, 2002), Dick et al. (2000) 
found that in pairs of female twins discordant for age of menarche, the early-maturing twin 
had greater substance use at age 16, but this association was non-significant in follow-up 
assessments at ages 17 and 18.5, indicative of early PD producing only a short-term shift in 
alcohol use trajectories.
The present study sought to address these existing limitations and expand on the findings of 
Dick et al. (2000) by utilizing an independent and equally large, prospective, population-
based sample of both male and female Finnish twins, followed longitudinally across four 
waves from age 12 to age 22, with multi-indicator scales of pubertal development in early 
adolescence. We examined the relationship between PD and alcohol, nicotine, and illicit 
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drug use across adolescence and into young adulthood, using hierarchical models to 
compare the effects between families and within twin pairs from the same family, and testing 
for mediation by peer and parental influences. Because of the mixed findings in the existing 
literature, this study intended to clarify five key aspects of the relationship between PD and 
substance use: 1) sex differences; 2) persistence or attenuation of the association from early 
adolescence to young adulthood; 3) mediation though peer and parental influences; 4) the 
role of the potential confounding factor of biological father absence; and 5) whether the 
association is upheld within families, eliminating between-family sources of confounding 
that may cause a spurious relationship.
Methods
Participants
Participants in this study were from the FinnTwin12 sample (Kaprio, et al., 2002; Kaprio, 
2006), a prospective longitudinal study of five sequential cohorts of Finnish twins with 
initial assessments in the year during which the twins were age 11–12 and continuing, at 
present, into their mid-20s. In Finland, all individuals are assigned a personal identification 
number at birth; this is linked to the biological mother and maintained in the Population 
Register Centre. From this registry, twins born from 1983 to 1987 were identified and 
contacted to participate in the FinnTwin12 study, permitting an unbiased sampling strategy 
that included all twins born in Finland during that time period who were living with one or 
both of their parents, residing in Finland, and enrolled in a regular school. The study was 
approved by the Ethics Committee of the Hospital District of Helsinki and Uusimaa and the 
IRB of Indiana University, Bloomington At the first assessment, 5,184 twins participated 
(50% female, 31% monozygotic [MZ], 32% same-sex dizygotic [DZ], 31% opposite-sex 
DZ, and 6% uncertain zygosity), with response rates at each wave of 85–90% (Kaprio, 
2013).
From the full twin sample, a subset of families was selected for more intensive study, 
including clinical interviews of twins at ages 14 and 22 and more extensive questionnaires 
across data collection waves. The sub-sample comprised about 40% of all twin pairs, who 
were selected mostly at random but with some oversampling for individuals at risk for 
alcohol problems (see Rose, Dick, Viken, Pulkkinen, and Kaprio [2004] for full details). Of 
the 1035 families selected for this subset, 90% and 73%, of the target sample participated at 
age 14 and age 22, respectively (age 14: n = 1854, 49% female; age 22: n = 1347, 53% 
female).
In the present study, we used data from the full epidemiological sample for most variables, 
supplemented by additional substance use variables that were assessed only in the intensive 
sample, as described below. Given the substantial differences between males and females in 
the timing and rates of PD as well as in adolescent substance use patterns and the effects of 
parental monitoring and peer substance use (Dick et al., 2007; Rose et al., 2001), we conduct 
all analyses with an examination of sex differences and use only same-sex twin pairs in 
order to facilitate within-family comparisons. Our final sample size was thus 3,632 
individuals for the epidemiological sample (49% female, 46% MZ, 45% DZ, 8% uncertain 
zygosity), of which 1,304 were also a part of the intensive subset.
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Measures
Participants were mailed questionnaires at age 11–12 (hereafter referred to as age 12), within 
2 months of their 14th birthday, within 3 months of being aged 17.5, and between ages 20–
26 (average age of 22; hereafter referred to as age 22). Individuals from the intensive sample 
participating in the clinical assessments completed the questionnaires onsite or returned 
them by mail. These questionnaires contained a variety of questions about subjects such as 
personality, home environment, peers, and substance use. Most items were repeated in each 
wave, although more extensive questions about own and peers’ use of alcohol, cigarettes, 
and other substances were included at age 14 and later. An additional questionnaire sent to 
the parent(s) at the initial assessment included questions about the home and family, 
including the presence or absence of the biological father in the rearing environment.
Pubertal development—At age 12, participants responded to the five-question Pubertal 
Development Scale (PDS; Petersen, Crockett, Richards, & Boxer, 1988), a commonly used 
self-report measure with established reliability and validity (Carskadon & Acebo, 1993; 
Petersen et al., 1988). This scale has three questions for both sexes, assessing growth in 
height, body hair, and skin changes, and two sex-specific questions (males: development of 
facial hair and voice change; females: breast development and menarche). Each question had 
four response categories (“growth/change has not begun”, “growth/change has barely 
started”, “growth/change is definitely underway”, and “growth/change seems complete”), 
except for menarche, which was dichotomous. The response item “seems complete” was left 
out at age 12 due to the expectation that few individuals at that age would have reached that 
advanced stage of development. The PDS was also administered at age 14, but we use only 
the age 12 measures in this study in order to assess early maturation.
Items for the PDS in this sample had an internal consistency (Cronbach’s α) of 0.40 for boys 
and 0.63 for girls. As the unidimensional nature of the PDS is well-established (and was 
upheld in exploratory factor analysis in this sample), scale items were combined into factor 
scores for each participant using a one-factor confirmatory factor analysis (CFA), which 
weights item contributions to the total score based on the strength with which the item 
relates to the underlying latent construct (that is, PD). CFA was conducted separately for 
males and females in the OpenMx package (Boker et al., 2011) for R version 2.15.3 (R Core 
Team, 2013), and factor scores were computed with two-stage, full information maximum 
likelihood estimation with Bayesian expected posterior methods (see Estabrook and Neale, 
2013), which take into account the binary/ordinal response structure of the items while also 
including individuals with missing or incomplete data. PD factor scores thus represent an 
individual’s level of PD at age 12 relative to their same-sex and same-age peers, with higher 
scores indicating earlier maturers.
Peer substance use—At ages 14 and 17, all participants were asked three questions 
regarding how many of their friends a) drink alcohol, b) smoke cigarettes, and c) use any 
kind of illicit drugs, with response items including “none”, “one”, “2–5”, or “more than 5”. 
These item sets had an internal consistency of α = 0.73/0.78 at age 14 for boys/girls, and 
0.64/0.73 at age 17. Items were combined into factor scores for each participant as described 
in the previous section.
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Parental monitoring—At ages 12 and 14, all participants were asked about how often 
their parents know a) their plans for each day, b) their interests, activities, and whereabouts 
each day, and c) where they are and who they are with when not at home. Response options 
were “almost always”, “usually”, “sometimes”, or “rarely or never”. The options 
“sometimes” and “rarely or never” were combined in the age 12 responses due to low 
frequencies of endorsement. These item sets had an internal consistency of α = 0.74/0.73 at 
age 12 for boys/girls, and 0.73/0.78 at age 14, and were combined into factor scores for each 
participant as previously described.
Self-reported substance use
Drinking frequency: At age 12, participants in the intensive subset were asked if they had 
initiated alcohol use (drinking with friends without parents around). At ages 14, 17, and 22, 
participants in the full sample were asked about current frequency of drinking, with four 
ordinal response options at age 14 (from “never/I don’t drink alcohol” to “once a week or 
more”), which were expanded to nine options at ages 17 and 22. These items were re-coded 
at each age into pseudo-continuous number of days drinking per month, using the median 
value of the option’s range where applicable (e.g. 1–2 times per month became 1.5 days).
Alcohol use disorder symptoms: At ages 14 and 22, participants from the intensive subset 
were administered the adolescent and adult versions of the Semi-Structured Assessment for 
the Genetics of Alcoholism (SSAGA; Bucholz et al., 1994; Hesselbrock, Easton, Bucholz, 
Schuckit, & Hesselbrock, 1999), which assessed alcohol abuse and alcohol dependence 
symptoms using criteria from the Diagnostic and Statistical Manual of Mental Disorders – 
IV (DSM-IV; American Psychiatric Association, 1994). Symptoms of either disorder were 
combined to form an overall alcohol use disorder (AUD) symptom count at age 14 (due to 
low frequency of endorsement of symptoms from either disorder) and of alcohol dependence 
symptoms at age 22.
Smoking frequency: At age 12, participants in the intensive subset were asked if they had 
initiated cigarette use. At ages 14, 17, and 22, participants in the full sample were asked if 
they had initiated cigarette use and, if so, about their current smoking frequency with four 
ordinal response options at age 14 (from “I have tried smoking but I don’t smoke” to “I 
smoke at least once each day”) and an additional categorical option of “I am trying to or 
have quit smoking”. These were expanded to eight ordinal response options at ages 17 and 
22, and responses were re-coded to a pseudo-continuous measure of number of cigarettes 
per month, again using median values for response options with a range of values. Non-
initiation was coded as a frequency of zero, while “trying to or have quit” was coded as 
missing, as the actual frequency of use could not be determined.
Illicit drug use: At age 17, participants in the full sample were asked how many times in 
their lifetime they had used any kind of illicit drugs, with five ordinal response levels from 
“never” to “20 or more times”. At age 22, participants in the intensive sample were asked 
how many times in their lifetime they had used each of the major categories of illicit drugs, 
using items from the SSAGA, while participants in the rest of the sample were asked about 
lifetime frequency of a) cannabis use and b) any other illicit drug use, using the same 
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response options as at age 17. Response options for age 22 were harmonized across these 
two assessment methods to create two items (cannabis or other illicit drugs) and were 
recoded, for both age 17 and age 22, as a pseudo-continuous number of lifetime uses.
Data Analysis
Our analytic strategy involved three major components. First, we quantified the phenotypic 
association between PD and substance use at each age with correlational analyses. Second, 
having established whether an association exists, we used twin modeling to determine 
whether this association might be due to a shared genetic or environmental etiology – e.g. 
the same genetic or environmental causal factors contributing to both early PD and 
substance use. Finally, of primary interest to this study, we conducted a multilevel structural 
equation model to estimate the longitudinal phenotypic relationship between PD and 
substance use and evaluate mediational and confounding factors influencing this 
relationship.
Genetically informative twin models—We used the twin sample to conduct 
genetically-informative multivariate twin modeling, which can identify the extent to which 
the covariance between two or more traits is due to genetic versus environmental causes 
being shared between the traits. Twin models can be used to partition the variance and 
covariance of traits into contributions from additive genetic (A), common environmental (C), 
and unique environmental (E) effects by comparing the relative within-trait and cross-trait 
similarity for MZ and DZ twins (Neale & Cardon, 1992). MZ twins share all of their genetic 
variation while DZ twins share about half of their segregating genetic variation, but both 
types of twins share their common environment (factors that contribute to within-family 
resemblance) to the same extent; thus the differences in trait similarity between MZ and DZ 
pairs is informative as to the contributions from A versus C. Unique environmental factors 
are individual exposures and experiences that make twins within pairs less similar to each 
other and make the MZ correlation less than unity. Using these principles, we fit Cholesky 
decomposition of variance models between PD factor scores and each set of substance use 
variables (drinking, AUD symptoms, smoking, and illicit drug use), as illustrated in Figure 
1. We conducted omnibus tests of the significance of each genetic and environmental source 
to the covariance between PD and substance use by constraining all covariance paths from 
an A/C/E source (e.g. the joint set of paths a21, a31, a41, and a51) to zero. The change in 
model fit between the full and constrained models was evaluated with a chi-square test of the 
difference in -2 times the loglikelihood between models, with p values < .05 indicating a 
significant decrease in model fit caused by the constrained parameters and thus the 
importance of that genetic or environmental source to the trait covariance. Twin models were 
fit in the OpenMx package (Boker et al., 2011) for R version 2.15.3 (R Core Team, 2013), 
using full information maximum likelihood estimation.
Multilevel longitudinal models—Next, we used a multilevel structural equation model 
to estimate the strength of the phenotypic relationship between PD and substance use across 
early adolescence through young adulthood, at the between-family and within-family levels. 
This model was also used to test whether this relationship was mediated by peer deviance/
parental monitoring, or accounted for by the confounding factor of biological father absence 
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that may be associated with both early PD and heavier substance use. A two-level model 
allowed for the estimation of these effects at the between-family population level, and at the 
within-family level in which within-pair differences in PD are used to predict within-pair 
differences in substance use outcomes, controlling for potential confounding factors that 
differ between families (Preacher, Zypher, & Zhang, 2010). The multilevel model was 
conducted for each substance use phenotype, including estimates of the direct effect of age 
12 PD on substance use at each age, controlling for its effect on substance use at previous 
ages, as well as the effects of peer substance use and parental monitoring on concurrent and 
later substance use, and their mediational paths between PD and substance use. The model 
also estimated (at the between-family level) the effects of biological father absence on PD, 
substance use, and each of the mediators. An illustrative example of these models is shown 
in Figure 2. Direct and indirect effects of PD on substance use were calculated for each 
substance use outcome at each assessment age.
We tested for sex/gender differences in these relationships by fitting each of these models 
separately by sex in a multi-group analysis, and then constraining the regression path 
coefficients to be equal across sexes and comparing the fit of the constrained model to the 
multi-group model with a chi-square test of the difference in -2 times the loglikelihood. 
Comparison of these models indicates whether there are differences in the relationships 
between variables as a function of sex (i.e. moderation effects) or simply sex differences in 
the variable means. All multilevel model analyses were conducted in Mplus version 7.31 
(Muthén & Muthén, 2012) using maximum likelihood estimation with robust standard 
errors.
Results
Descriptive Statistics and Correlations
Table 1 presents descriptive statistics for the substance use variables and their correlations 
with age 12 PD factor scores for males and females. The correlations between PD and 
substance use were virtually all positive but modest (0.19 or less), with general trends of the 
strongest correlations being with age 14 substance use, and stronger correlations for females 
than males. One exception to this trend was a correlation of 0.12 between PD and age 22 
smoking frequency for males (female correlation of 0.05, n.s.). Consistent with the theorized 
relationship between PD and parent/peer interactions, early PD was correlated with higher 
peer substance use (r = 0.06 to 0.11) and lower levels of parental monitoring (r = −0.07 to 
−0.14).
Genetically informative twin models
Multivariate twin Cholesky models were fit to each longitudinal set of substance use 
variables to determine whether the observed relationship between PD and substance use was 
due to a shared genetic or environmental etiology. From each full model, genetic (A), 
common environmental (C) or unique environmental (E) covariance paths between PD and 
each substance use measure were fixed to zero, and the change in model fit was evaluated. 
We also tested for overall significance of a shared liability between PD and substance use by 
dropping all A, C, and E covariance paths at once. When the covariance paths cannot be 
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dropped from the model without a significant (chi-square test p < .05) decrease in fit, this 
indicates a significant shared genetic or environmental etiology between PD and substance 
use.
Table 2 presents the covariance path estimates from these Cholesky models and the fit 
indices comparing the change in model fit of the nested sub-models (A/C/E covariance paths 
dropped) versus the full multivariate model illustrated in Fig. 1. Omnibus tests of the nested 
models indicated that there was little overlap in the genetic or environmental factors 
contributing to PD and substance use; indeed, for males, all shared A, C, and E paths could 
be dropped for all substances without a significant decrement in model fit. For females, there 
was a significant overlap between PD and drinking frequency that was primarily driven by 
shared common environmental (C) factors and unique environmental (E) factors at age 14, 
Similarly for smoking frequency in females, overall E influences were shared with PD, and 
were most strongly shared at age 14. There was no significant overlap in sources of 
covariance between PD and AUD symptoms. A, C, and E influences were shared between 
PD and illicit drug use at age 22 for females, although notably the genetic (A) covariance 
was in a negative direction, such that the genes contributing to early PD were associated 
with less frequent illicit drug use at age 22. We present only the PD-substance use 
covariance paths here; additional results from the multivariate twin models are available in 
Supplemental Table S1 or upon request from the first author.
Multilevel Longitudinal Models
We next fit a series of two-level structural equation models for each set of substance use 
measures to examine the longitudinal relationship between PD and substance use at the 
between- and within-family levels, testing for mediational and confounding effects of the 
environmental factors of peer substance use, parental monitoring, and biological father 
absence. We first tested whether the associations between variables in the model could be 
equated for males and females, and found that, for all outcomes, constraining the path 
estimates to equality led to a highly significant decrease in model fit (Supplementary Table 
S2). This indicated that the patterns of relationships between variables differed between the 
sexes (interaction effects), beyond simple sex differences in the variable means. We 
therefore focus the rest of our presentation of results on those from the multi-group sex 
models.
Estimates of the effect of age 12 PD on substance use measures at each age are presented 
separately for males and females in Table 3, with the between-family level effects in the left-
hand column and the within-family level effects on the right. In Table 3, the direct effects of 
PD can be interpreted as the regression coefficient from a single measurement of substance 
use being regressed on age 12 PD (e.g. paths a1, a2, a3, or a4 in Fig. 2). The indirect effects, 
in parentheses, encompass the sum of all indirect paths between PD and the specified 
substance use measure, including the autoregressive association (for example, PD’s 
association with substance use at age 17 through its cumulative effects from ages 12 and 14, 
paths a1* d12* d23), and the association through all connecting mediational paths. The 
direct and indirect effects can be summed to calculate the total effect of early PD on 
substance use at the specified age; i.e. what the regression coefficient would be for a 
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univariate analysis that did not include mediation effects or covariates. We summarize 
results from this table relevant to each part of the research question in the sections below.
Longitudinal effects of PD on substance use—Although the focus of presentation is 
on the within family effects, we briefly note that at the between-family level (Table 3, left 
column), early PD was associated with higher levels of each of the four substance use 
outcomes at one or more ages assessed in this study, consistent with previous cross-sectional 
reports. These associations were largely through indirect (mediational) effects, were 
generally more evident in females than males, and each showed a decreasing trend in the 
magnitude and/or significance of association across time, particularly between the age 17 
and age 22 assessment. A positive association between PD and smoking frequency was 
observed at age 22 in both sexes, which was unique in being the only direct path persisting 
in an association beyond age 14.
Early PD and substance use had a different and more subtle pattern of association at the 
within-family level (Table 3, right column). Within twin pairs, PD was associated with a 
higher likelihood of drinking initiation at age 12 and (indirectly) a modestly higher drinking 
frequency at age 14 in females, with no significant associations for males. The effect size 
decreased across adolescence, with negative – although non-significant – associations at age 
22. The same pattern was seen for AUD symptoms: a positive association at age 14 in girls, 
reversing direction across time such that by age 22, the early maturing twin in both male and 
female pairs was predicted to have fewer alcohol problems than the later maturing co-twin. 
Smoking initiation at age 12 was more likely for the early maturer in female pairs, as was a 
higher smoking frequency at ages 14–22 in both sexes, although the effect was modest in 
general and not significant at age 17 for girls. Of note, the direction of association for the 
direct effects of PD reversed at age 22 and became negative in both sexes; however, the 
stronger and positive indirect effects leave the balance of the total effects in the positive 
direction. Early PD also had a positive association with illicit drug use, evident in significant 
direct effects on age 17 drug use and age 22 cannabis use for males, as well as significant 
indirect effects on age 22 use of other illicit drugs for both sexes. Longitudinal trends of 
attenuation in effect size were similar at the within-family level as observed at the between-
family level, although they uniquely demonstrated a reversal in the direction of association 
by young adulthood – particularly for alcohol use outcomes.
Mediation by peer substance use and parental monitoring—The hypothesized 
peer and parenting mediating variables showed the expected relationship with substance use. 
At the between-family level, early PD was related to higher peer substance use at age 14 and 
age 17 for both males and females, and to lower parental monitoring in males (negative but 
not significant for females; see Supplemental Table S3). However, this association was not 
upheld at the within-family level, where the early-maturing twin only among female pairs 
reported lower levels of parental monitoring at age 12 and 14 (β = −0.11 to −0.14, p < .01), 
and there were no differences in peer substance use related to PD (Supplemental Table S4). 
At both the between- and within-family levels, peer substance use and parental monitoring 
were themselves associated with higher and lower substance use, respectively, across each 
type of substance. This held for both males and females, though the significant associations 
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were virtually all cross-sectional within age/measurement occasion (Supplemental Table 
S4). As mentioned above, the indirect effects of PD on substance use through these 
mediational pathways were substantial at the between-family level (Table 3). Within 
families, mediational effects were influential only for smoking and illicit drug use after early 
adolescence. We note that of the significant within-family indirect effects shown in Table 3, 
64–88% of the indirect effects for smoking and 54–94% of the indirect effects for illicit drug 
use were attributable to cumulative autoregressive effects (‘d’ paths, Fig. 2) rather than the 
peer/parenting mediational effects (‘b’/‘c’ paths, Fig. 2).
Effects of absence of the biological father—Having an absent biological father was 
associated with higher PD scores in males (M = 0.19 versus M = 0.04 for father-absent 
versus father-present boys, t[1450] = 3.55, p < .01), but not females (M = 0.02 versus M = 
0.01 for father-absent versus father-present girls, t[1304] = 0.25, p = .80). Removing 
biological father absence as a predictor of PD and substance use in the multi-level models 
led to virtually no changes in the parameter estimates of the effects of PD (see 
Supplementary Table S5).
Discussion
The present study examined associations between early pubertal development and 
adolescent/young adult substance use in a population-based, longitudinal sample of Finnish 
twins. The unique properties of the twin sample allowed us to disentangle the relationship 
between PD and substance use by estimating the genetic versus environmental contributions 
to their association and by controlling for potential confounding factors that differ 
systematically between families and predict both early PD and substance use. Broadly, our 
findings suggest that the previously reported associations between early PD and greater 
adolescent alcohol use/problems may be only modest and limited to early adolescence, while 
early PD appears to have longer lasting associations with nicotine and illicit drug use. We 
highlight the major takeaways from this study below.
1. Findings from previous studies of an association between early PD and 
adolescent substance use were replicated. At the between-family level, which 
is comparable to studies using population-based samples, PD was associated 
with heavier use of multiple substances for both sexes. The magnitude of the 
effect sizes were modest, with PD accounting for, at most, an expected difference 
of less than half a drinking day per month, 0.2 AUD symptoms, 15 cigarettes per 
month, or one lifetime use of an illicit drug. The strength of association decayed 
with age, in line with the numerous reports of an association in early/mid-
adolescence but less consistent results in young adulthood. We also replicated 
previous findings that these substance use associations were largely due to 
indirect effects through peer substance use, parental monitoring, and cumulative 
effects on substance use over time.
2. The association between PD and substance use is partially attributable to 
confounding factors that differ between families. The within-family models 
provided a robust test for a true association between early PD and substance use, 
controlling for many potential causes of spuriousness. Within pairs, the 
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magnitude of the effects of PD were attenuated relative to that observed at the 
population level, and even reversed in direction in some cases. In addition, 
though mediational effects were robust at the between-family level, there was 
little evidence for them within pairs. These findings suggest that the mediational 
effects of peer substance use and parenting found in other studies (e.g. 
Schelleman-Offermans et al., 2013) more likely reflect correlated liabilities to 
early PD, substance use, and peer/parenting factors that differ systematically 
between families and may share a common underlying cause. Importantly 
though, outside of any relation to PD, within-pair differences in peer substance 
use and in parental monitoring were linked to heavier substance use, indicative of 
the importance of these as targetable risk factors for adolescent and young adult 
substance use.
3. Any shared causal factors overlapping between early PD and heavier 
substance use are likely to be environmental rather than genetic in nature. 
Results from the twin Cholesky models indicated that, for females, some of the 
same environmental influences contributed to both early PD and heavier 
drinking/smoking in early adolescence and illicit drug use in young adulthood. 
This is consistent with the single other study examining multivariate biometric 
models of PD and substance use, which found evidence only for shared common 
environmental factors, and not genetic factors, between girls’ adolescent drinking 
frequency and age at menarche (Dick et al., 2000). Lack of overlap in any of 
these factors for males may be a result of the less robust phenotypic correlation, 
or may be indicative of a (modest) causal association between the traits rather 
than a shared liability. Duffy & Martin (1994) discuss the difficulty in 
distinguishing a shared liability from a phenotypic causal association when using 
twin models, especially if both traits have a similar genetic architecture (here, PD 
and substance use were each moderately heritable).
4. Biological father absence does not explain the association between PD and 
substance use, but was associated with early PD in males. In contrast to a 
number of previous studies, biological father absence had no relationship to PD 
in females. This discrepancy may be due to differences in measures of PD, as 
most studies have used retrospective accounts of age at menarche as their 
definition of PD (Bogaert, 2005; Kim & Smith, 1998; Quinlan, 2003). A 
previous study examining the associations between individual PD indicators 
(PDS scale items) and biological father absence found that not all indicators 
differed significantly between father-present and father-absent individuals, with 
menarche showing the greatest difference for females, and overall somewhat 
greater differences for males than for females (Mustanski et al., 2004).
5. Sex differences are important to consider. There were sex differences in the 
pattern of relationships for each substance, with females generally having an 
earlier age of onset for when these associations emerge (perhaps unsurprising 
given the earlier average age of pubertal onset for girls). PD was more strongly 
associated with alcohol outcomes and parental monitoring levels for females, 
while the association between PD and illicit drug use was stronger for males.
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6. The pattern of association weakens or reverses across time, indicative of a 
“catch-up” effect, although it differs by substance. For drinking frequency 
and AUD symptoms, the within-family direction of association reversed at age 
22, such that early PD was associated with lower alcohol use/problems in young 
adulthood. These results are consistent with a “catch-up” effect that may be due 
to early maturers peaking earlier and beginning to decline in their substance use 
as their later-maturing counterparts are reaching peak use. Nevertheless, two 
previous studies have found that adolescent alcohol use predicted drinking 
problems in middle adulthood more so than in young adulthood (Huurre et al., 
2010; Pitkänen, Kokko, Lyyra, & Pulkkinen, 2008), so caution should be taken in 
extending these findings beyond the ages here included. Normative high levels of 
substance use in young adulthood may dilute the associations during that limited 
time period.
For smoking frequency, although there was a similar decrease in the total effects and a 
reversal in direction of the direct effects across time, early PD retained a modestly 
significant association with heavier smoking frequency at age 22 through indirect pathways. 
This may be evidence of the potential importance of PD on setting individuals on divergent 
developmental trajectories of nicotine use through subtler mechanisms, such as early 
initiation that leads to long-term, persistent addiction rather than transient, adolescent-
limited increases in smoking. In particular, normative (but temporary) high levels of 
substance use in mid- to late adolescence could mask a more lasting effect that emerges 
among early initiators who become addicted and persist in heavy use in adulthood, which 
could explain the population-level correlation seen between PD and age 22 smoking. While 
drinking in adolescence has been largely attributed to shared environmental factors such as 
peer influences (Pagan et al., 2006), some evidence from animal models suggests that 
adolescence is a critical time for the neurodevelopmental changes related to the development 
of nicotine addiction (Brielmaier, McDonald & Smith, 2007). A co-twin control study of 
MZ twins differing in age of onset of smoking by two years or greater found that the co-
twins with earlier onset had increased risk of nicotine dependence in adulthood (Kendler, 
Myers, Damaj, & Chen, 2013), while Hartz et al., (2012) demonstrated that early onset of 
smoking can moderate one’s genetic risk for nicotine dependence. If this is the case, early 
PD may be a risk factor for adult nicotine dependence via its effect on increasing likelihood 
of initiation of regular smoking during a critical neurodevelopmental stage.
Research is needed on whether this may be similarly true for illicit drug use, for which PD 
also showed persistent indirect effects on heavier use at age 22. An alternative explanation 
may be important to consider: given the epidemiological differences in timing of onset and 
peak use of illicit drugs versus alcohol and nicotine (e.g. Substance Abuse and Mental 
Health Services Administration, 2011), it may be that the associations with illicit drug use 
simply represent a time shift which would dissipate at older ages that were not assessed in 
this study. We might see, as with alcohol, that early maturers peak in initiation and use 
sooner and the trajectory for late maturers is just shifted by a few years. The link between 
PD and illicit drug use is in need of further investigation, especially with longer-term follow-
up. Differences in the addictiveness of substances (i.e. likelihood and speed of transition to 
dependence given initiation; Lopez-Quintero et al., 2011) may be an important determinant 
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of why early initiation leads to more or less temporary effects on long-term use trajectories 
for different substances. Future research across all substances is required to better 
understand what causal links, rather than correlated liabilities, may exist between factors that 
increase earlier initiation of substance use and long-term outcomes of substance use beyond 
the transient influences of adolescence.
Limitations
The findings of this study should be viewed in the context of several limitations. First, with 
the exception of the structured clinical assessments in the intensive subsample, most data 
were collected via self-report of questionnaires completed at home, which may have been 
influenced by social desirability biases or parental presence (especially regarding substance 
use variables in individuals below the legal age). While smoking and alcohol use patterns in 
Finnish adolescents and young adults are broadly comparable to other European and US 
populations, illicit drug use has until recently been much less common in Finland. Thus, 
replication of these analyses in other populations is needed. Participants also reported on the 
actions of others, including peer substance use and parental monitoring, which may reflect 
perceived rather than actual behaviors. The items indexing parental monitoring, for example, 
may thus reflect parental knowledge or the child’s willingness to disclose information to 
parents, which may differ from a true measure of “monitoring” and accordingly may have 
different associations with PD and/or substance use. However, previous research has found 
that child rather than parent reports of parenting behaviors are more reliably associated with 
the child’s substance use behaviors (Varvil-Weld, Turrisi, Scaglione, Mallett, & Ray, 2013), 
and that perceived rather than actual peer substance use is most strongly associated with 
one’s own substance use (Iannotti & Bush, 1992). Second, given the complexity of the 
models and sample attrition at older ages, estimates may be somewhat imprecise and we 
may have been underpowered to detect small effects of PD and to disentangle genetic versus 
environmental sources of variance in the biometric models when the magnitude of the 
effects themselves are very small. Third, participants were measured at the same age for 
assessments of PD; while this limits potential confounding effects of age differences in the 
sample, limited variance from a single time-point measure of a developmentally dynamic 
construct may have attenuated the associations seen between PD and other outcomes.
In addition, as this was a longitudinal study, there is a risk of differential attrition. We 
compared age 12 and age 14 data from individuals who remained or dropped out of the 
study after the age 14 wave, and although participant retention was high, there were some 
significant differences. Those who dropped out were more likely to be male, to smoke and 
drink more at 14 (but no differences in substance use at age 12), to have more AUD 
symptoms at age 14, and to have lower age 12 PD scores (late developers), higher peer 
substance use scores, and lower parental monitoring scores. However, this should bias our 
results in a conservative rather than liberal direction, based on the directions of the 
associations that were found. This study also has numerous strengths, including unbiased 
population ascertainment, longitudinal data collection beyond adolescence with high 
retention rates, PD scores derived from multiple indicators to decrease the error associated 
with single-items such as age as menarche, comparisons of gender differences using data 
collected with the same measures, and the use of twin pairs to control for many of the 
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between-family confounds that make it difficult to understand the nature of the relationship 
between PD and substance use.
Conclusion
Early pubertal development has a long but conflicted history of association with an increased 
risk for numerous emotional and behavioral health outcomes in adolescence, including 
substance use. The current study, using a large, longitudinal, epidemiological sample of 
twins, shed light on several issues muddying the nature of this association. We conclude that, 
although evident that the association exists, it is a relatively modest effect and has a nuanced 
presentation depending on gender, age, and substance use measure, which perhaps explains 
why discrepancies may be seen across studies and especially across samples of different 
ages. A substantial portion of the association is due to confounding factors that differ 
between families and represent correlated liabilities shared between early maturation and 
heavier substance use. Such correlated liabilities appear to be attributable to environmental 
rather than biological factors, and cannot be explained by absence of the biological father. In 
addition, the association between early PD and higher alcohol use/problems was limited to 
early adolescence and was consistent with a “catch-up” effect. Our findings indicate that the 
early PD may have more robust and persistent effects on adult nicotine use through divergent 
trajectories beginning earlier in adolescence. These effects are not solely due to mediation 
by peer and parental factors, and further research is necessary to identify other pathways that 
may explain this association. Within-family differences in peer substance use and parental 
monitoring, however, were themselves associated with differences in substance use between 
co-twins; these factors may thus be useful targets for prevention/intervention efforts. This 
study’s findings highlight the complexity of the association between early maturation and 
substance use, and illustrate the need to consider many overlapping factors and alternative 
explanations in order to fully understand their relationship.
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Figure 1. 
Theoretical model of a Cholesky decomposition of variance between pubertal development 
(PD) and substance use (SU). For ease of presentation, only the additive genetic (A) factors 
are shown; identical sets of paths for common environmental (C) and unique environmental 
(E) factors are in the full model, and these sets of paths are correlated between twins within 
pairs based on the principles of biometrical modeling (see text).
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Figure 2. 
Diagram of the multilevel structural equation model of the relationship between pubertal 
development (PD), substance use (SU) across adolescence and young adulthood, and 
hypothesized mediating/confounding factors (peer substance use [Peer] and parental 
monitoring [Mon]).
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m
a
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m
a
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R
IN
K
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G
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0.
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.01
)
−
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)
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*
*
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(0.
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)
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 (0
.09
*
)
0.
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*
*
*
)
−
0.
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 (0
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)
0.
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 (0
.03
*
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−
0.
09
 (0
.34
*
)
−
0.
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 (0
.25
*
*
*
)
−
0.
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 (0
.06
)
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0.0
1)
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0.
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 (0
.25
)
0.
04
 (0
.10
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−
0.
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1)
−
0.
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A
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O
H
O
L 
U
SE
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O
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ER
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Y
M
PT
O
M
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.05
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)
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*
*
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)
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−
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O
K
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−
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*
)
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)
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)
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*
*
*
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)
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−
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 (0
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*
)
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.24
*
*
)
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*
 
(0.
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)
0.
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 (0
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*
)
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−
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 (4
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*
)
−
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 (3
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*
*
*
)
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(1.
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*
)
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51
 (0
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)
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(3.
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)
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)
−
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 (2
.43
*
)
−
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−
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 (0
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)
−
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 (0
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*
*
)
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44
*
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(0.
02
)
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 (0
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)
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)
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)
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)
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.11
)
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N
ot
e:
 D
ire
ct
 e
ffe
ct
s o
f P
D
 o
n 
su
bs
ta
nc
e 
us
e 
at
 e
ac
h 
ag
e 
ar
e 
sh
ow
n
, 
w
ith
 in
di
re
ct
 e
ffe
ct
s i
n 
pa
re
nt
he
se
s. 
D
ire
ct
 e
ffe
ct
s a
re
 th
e 
re
gr
es
sio
n 
co
ef
fic
ie
nt
s f
ro
m
 a
 si
ng
le
 m
ea
su
re
m
en
t o
f s
ub
sta
nc
e 
us
e 
be
in
g 
re
gr
es
se
d 
on
 P
D
 (p
ath
s a
1, 
a2
, a
3, 
or 
a4
 in
 Fi
g. 
2).
 In
dir
ec
t e
ffe
ct
s s
um
 a
ll 
pa
th
s b
et
w
ee
n 
PD
 a
nd
 su
bs
ta
nc
e 
us
e,
 in
cl
ud
in
g 
bo
th
 th
e 
au
to
re
gr
es
siv
e 
as
so
ci
at
io
n 
(e.
g. 
PD
’s 
ass
oc
iat
ion
 w
ith
 su
bs
tan
ce
 us
e a
t a
ge
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 th
ro
ug
h 
its
 c
um
ul
at
iv
e 
as
so
ci
at
io
ns
 a
t e
ar
lie
r a
ge
s, 
ca
lc
ul
at
ed
 a
s p
at
hs
 a
1 
* 
d1
2*
 d
23
) a
nd
 th
e m
ed
iat
ion
al 
pa
ths
 th
rou
gh
 pe
er 
su
bs
tan
ce
 us
e a
nd
 pa
ren
tal
 m
on
ito
rin
g (
see
 Fi
g. 
2).
*
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< 
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*
*
p 
< 
.0
1,
*
*
*
p 
< 
.0
01
.
a C
an
na
bi
s u
se
;
b o
th
er
 il
lic
it 
dr
ug
 u
se
.
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